Identification of miR-29c and its Target FBXO31 as a Key Regulatory Mechanism in Esophageal Cancer Chemoresistance: Functional Validation and Clinical Significance-Reference-Cited by-同舟云学术

Identification of miR-29c and its Target FBXO31 as a Key Regulatory Mechanism in Esophageal Cancer Chemoresistance: Functional Validation and Clinical Significance

Published:2019 Issue:6 Volume:9 Page:1599-1613
ISSN:1838-7640
Container-title:Theranostics
language:en
Short-container-title:Theranostics

Author:

Li Bin,Hong Pan,Zheng Can-Can,Dai Wei,Chen Wen-You,Yang Qing-Sheng,Han Liang,Tsao Sai Wah,Chan Kin Tak,Lee Nikki Pui Yue,Law Simon,Xu Li Yan,Li En Min,Chan Kwok Wah,Qin Yan Ru,Guan Xin Yuan,Lung Maria Li,He Qing-Yu,Xu Wen Wen,Cheung Annie LM

Publisher

Ivyspring International Publisher

Subject

Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Medicine (miscellaneous)

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pristimerin exhibits anti-cancer activity by inducing ER stress and AKT/GSK3β pathway through increasing intracellular ROS production in human esophageal cancer cells;Toxicology in Vitro;2024-08

2. HMGA1 promotes the progression of esophageal squamous cell carcinoma by elevating TKT-mediated upregulation of pentose phosphate pathway;Cell Death & Disease;2024-07-30

3. Aloperine Suppresses Cancer Progression by Interacting with VPS4A to Inhibit Autophagosome‐lysosome Fusion in NSCLC;Advanced Science;2024-06-21

4. LncRNA RGMB-AS1 inhibits HMOX1 ubiquitination and NAA10 activation to induce ferroptosis in non-small cell lung cancer;Cancer Letters;2024-05

5. The dual role of LOXL4 in the pathogenesis and development of human malignant tumors: a narrative review;Translational Cancer Research;2024-04